Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Ani Pharmaceuticals (ANIP) over the last 15 years, with Q3 2025 value amounting to 0.07%.

  • Ani Pharmaceuticals' Return on Capital Employed rose 500.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.0% for FY2024, which is 700.0% down from last year.
  • According to the latest figures from Q3 2025, Ani Pharmaceuticals' Return on Capital Employed is 0.07%, which was up 500.0% from 0.01% recorded in Q2 2025.
  • Ani Pharmaceuticals' Return on Capital Employed's 5-year high stood at 0.07% during Q1 2024, with a 5-year trough of 0.09% in Q3 2022.
  • In the last 5 years, Ani Pharmaceuticals' Return on Capital Employed had a median value of 0.0% in 2024 and averaged 0.01%.
  • Per our database at Business Quant, Ani Pharmaceuticals' Return on Capital Employed crashed by -800bps in 2022 and then soared by 1500bps in 2023.
  • Quarter analysis of 5 years shows Ani Pharmaceuticals' Return on Capital Employed stood at 0.07% in 2021, then increased by 27bps to 0.05% in 2022, then surged by 215bps to 0.06% in 2023, then plummeted by -99bps to 0.0% in 2024, then soared by 12073bps to 0.07% in 2025.
  • Its Return on Capital Employed stands at 0.07% for Q3 2025, versus 0.01% for Q2 2025 and 0.01% for Q1 2025.